Screener / SEC EDGAR /CIK 0001607678 /10-K filed Feb 11, 2026, compared with Feb 26, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Viking Therapeutics, Inc. VKTX

Compare with peers Embed
Planned sales, announced before they happen

2 trading plans running, 7 Form 144 notices for $18.3M

10-Q, 10-K and Form 144

What VKTX's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Jan 15, 2026 to Dec 8, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.

InsiderWhatDateReported in
Charles A. Rowland
Director
Adopted 10b5-1 plan Sep 4, 2026 10-Q Oct 29, 2026
J. Matthew Singleton
Director
Ended 10b5-1 plan Aug 14, 2026 10-Q Jul 24, 2024
Marianne Mancini
Chief Operations Officer
Ended 10b5-1 plan Feb 16, 2026 10-Q Apr 24, 2025
Brian Lian
Chief Executive Officer
Adopted 10b5-1 plan Jan 15, 2026 10-Q Apr 30, 2026
Brian Lian
Chief Executive Officer
Ended 10b5-1 plan Dec 31, 2025 10-Q Apr 24, 2025
Lawson Macartney
Director
Ended 10b5-1 plan Sep 30, 2025 10-K Feb 26, 2025
Sarah K. Rouan
Director
Ended 10b5-1 plan Aug 19, 2025 10-Q Jul 24, 2024
Brian Lian
President, Chief Executive Officer and Director
Ended 10b5-1 plan Aug 8, 2025 10-Q Jul 24, 2024
Marianne Mancini
Chief Operations Officer
Ended plan Apr 20, 2025 10-Q Apr 25, 2024
Greg Zante
Chief Financial Officer
Ended 10b5-1 plan Mar 31, 2025 10-Q Oct 23, 2024
Lawson Macartney, Ph.D
Director
Ended 10b5-1 plan Feb 21, 2025 10-Q Jul 24, 2024
Greg Zante
Chief Financial Officer
Ended plan Aug 1, 2024 10-Q Apr 25, 2024
Show the other 4 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since Apr 26, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Jul 29, 2026 BRIAN LIAN
Officer
148,517 $4.9M
Jul 29, 2026 GREG ZANTE
Officer
21,217 $710K
Jul 29, 2026 MARIANNA MANCINI
Officer
18,217 $610K
Jan 5, 2026 MARIANNA MANCINI
Officer
57,661 $1.9M
Jan 5, 2026 GREG ZANTE
Officer
57,661 $1.9M
Jan 5, 2026 BRIAN LIAN
Officer
233,409 $7.7M
Jan 2, 2026 MATTHEW W. FOEHR
Director
16,000 $562K

From the Form 144 XML filed with the SEC, since Jan 2, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/VKTX/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.